James L Tyree - Net Worth and Insider Trading
James L Tyree Net Worth
The estimated net worth of James L Tyree is at least $16 Million dollars as of 2024-07-08. James L Tyree is the Executive Vice President of Abbott Laboratories and owns about 132,176 shares of Abbott Laboratories (ABT) stock worth over $14 Million. James L Tyree is the Director of ChemoCentryx Inc and owns about 19,138 shares of ChemoCentryx Inc (CCXI) stock worth over $994,985. James L Tyree is also the Director of Innoviva Inc and owns about 50,697 shares of Innoviva Inc (INVA) stock worth over $829,403. Besides these, James L Tyree also holds Assertio Holdings Inc (ASRT) , Genelux Corp (GNLX) . Details can be seen in James L Tyree's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James L Tyree has not made any transactions after 2024-03-14 and currently still holds the listed stock(s).
Transaction Summary of James L Tyree
James L Tyree Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James L Tyree owns 5 companies in total, including ChemoCentryx Inc (CCXI) , Assertio Holdings Inc (ASRT) , and Innoviva Inc (INVA) among others .
Click here to see the complete history of James L Tyree’s form 4 insider trades.
Insider Ownership Summary of James L Tyree
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CCXI | ChemoCentryx Inc | 2022-06-09 | director |
ASRT | Assertio Holdings Inc | 2024-03-14 | director |
INVA | Innoviva Inc | 2016-05-18 | director |
2009-02-27 | Senior Vice President | ||
2023-12-13 | director |
James L Tyree Latest Holdings Summary
James L Tyree currently owns a total of 5 stocks. Among these stocks, James L Tyree owns 132,176 shares of Abbott Laboratories (ABT) as of February 27, 2009, with a value of $14 Million and a weighting of 86.74%. James L Tyree owns 19,138 shares of ChemoCentryx Inc (CCXI) as of June 9, 2022, with a value of $994,985 and a weighting of 6.28%. James L Tyree also owns 50,697 shares of Innoviva Inc (INVA) as of May 18, 2016, with a value of $829,403 and a weighting of 5.23%. The other 2 stocks Assertio Holdings Inc (ASRT) , Genelux Corp (GNLX) have a combined weighting of 1.75% among all his current holdings.
Latest Holdings of James L Tyree
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABT | Abbott Laboratories | 2009-02-27 | 132,176 | 104.02 | 13,748,948 |
CCXI | ChemoCentryx Inc | 2022-06-09 | 19,138 | 51.99 | 994,985 |
INVA | Innoviva Inc | 2016-05-18 | 50,697 | 16.36 | 829,403 |
ASRT | Assertio Holdings Inc | 2024-03-14 | 188,251 | 1.44 | 271,081 |
GNLX | Genelux Corp | 2023-12-13 | 3,460 | 1.98 | 6,851 |
Holding Weightings of James L Tyree
James L Tyree Form 4 Trading Tracker
According to the SEC Form 4 filings, James L Tyree has made a total of 0 transactions in Abbott Laboratories (ABT) over the past 5 years. The most-recent trade in Abbott Laboratories is the sale of 10,454 shares on February 27, 2009, which brought James L Tyree around $498,447.
According to the SEC Form 4 filings, James L Tyree has made a total of 4 transactions in ChemoCentryx Inc (CCXI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in ChemoCentryx Inc is the sale of 3,863 shares on June 9, 2022, which brought James L Tyree around $99,125.
According to the SEC Form 4 filings, James L Tyree has made a total of 0 transactions in Innoviva Inc (INVA) over the past 5 years. The most-recent trade in Innoviva Inc is the sale of 813 shares on May 18, 2016, which brought James L Tyree around $8,512.
More details on James L Tyree's insider transactions can be found in the Insider Trading History of James L Tyree table.Insider Trading History of James L Tyree
- 1
James L Tyree Trading Performance
James L Tyree Ownership Network
Ownership Network List of James L Tyree
Ownership Network Relation of James L Tyree
James L Tyree Owned Company Details
What does ChemoCentryx Inc do?
Who are the key executives at ChemoCentryx Inc?
James L Tyree is the director of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , director & 10 percent owner & President & CEO and Director Thomas J. Schall , and SVP & Finance & Acctg Officer Yi Ching Yau .
ChemoCentryx Inc (CCXI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
ChemoCentryx Inc Insider Transactions
James L Tyree Mailing Address
Above is the net worth, insider trading, and ownership report for James L Tyree. You might contact James L Tyree via mailing address: 100 Abbott Park Road, Abbott Park Il 60064-6400.